“…It is the most common myeloid leukemia in adults 3 , 4 . Previous research in our laboratory have shown that the prognosis of AML is closely related to immune checkpoints 5 - 7 . In the era of tumor immunotherapy, the impact of inflammatory pathways on the effectiveness of anti-tumor immunity and tumor progression is increasing evident 8 - 10 .…”